Clinical Trial

Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated November 18, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of the study was to evaluate the efficacy of 611 in Chinese Adolescents with moderate to severe atopic dermatitis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-19.
Status change: Not Yet Recruiting → Recruiting 2025-11-16
Trial Details
NCT Number NCT07042126
Lead Sponsor Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions Dermatitis, Atopic
Enrollment 180 participants
Start Date 2025-08-05
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-18